BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15289009)

  • 1. Telomeres and telomerase in normal and leukemic hematopoietic cells.
    Engelhardt M; Wäsch R; Guo Y
    Leuk Res; 2004 Oct; 28(10):1001-4. PubMed ID: 15289009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase activity in myelodysplastic syndromes.
    Gürkan E; Tanriverdi K; Başlamişli F
    Leuk Res; 2005 Oct; 29(10):1131-9. PubMed ID: 16111531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture.
    Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA
    Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere shortening and chromosomal instability in myelodysplastic syndromes.
    Lange K; Holm L; Vang Nielsen K; Hahn A; Hofmann W; Kreipe H; Schlegelberger B; Göhring G
    Genes Chromosomes Cancer; 2010 Mar; 49(3):260-9. PubMed ID: 19998444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis?
    Sieglová Z; Zilovcová S; Cermák J; Ríhová H; Brezinová D; Dvoráková R; Marková M; Maaloufová J; Sajdová J; Brezinová J; Zemanová Z; Michalová K
    Leuk Res; 2004 Oct; 28(10):1013-21. PubMed ID: 15289012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomeres and telomerase in hematologic neoplasia.
    Ohyashiki JH; Sashida G; Tauchi T; Ohyashiki K
    Oncogene; 2002 Jan; 21(4):680-7. PubMed ID: 11850796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.
    Gancarcíková M; Zemanová Z; Brezinová J; Berková A; Vcelíková S; Smigová J; Michalová K
    Prague Med Rep; 2010; 111(2):91-105. PubMed ID: 20653999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies.
    Hills M; Lansdorp PM
    Ann N Y Acad Sci; 2009 Sep; 1176():178-90. PubMed ID: 19796246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concise review: Telomere biology in normal and leukemic hematopoietic stem cells.
    Drummond MW; Balabanov S; Holyoake TL; Brummendorf TH
    Stem Cells; 2007 Aug; 25(8):1853-61. PubMed ID: 17510216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of telomerase activity and telomere length in acute myelogenous leukemia].
    Liu L; Sun B; Liang Y
    Zhonghua Xue Ye Xue Za Zhi; 2001 Nov; 22(11):592-4. PubMed ID: 11855149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes.
    Swiggers SJ; Kuijpers MA; de Cort MJ; Beverloo HB; Zijlmans JM
    Genes Chromosomes Cancer; 2006 Mar; 45(3):247-56. PubMed ID: 16281260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomere length and hTERT expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities.
    Hartmann U; Brümmendorf TH; Balabanov S; Thiede C; Illme T; Schaich M
    Haematologica; 2005 Mar; 90(3):307-16. PubMed ID: 15749662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
    Harada Y; Harada H
    J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Telomere, telomerase and cytogenetic changes in myelodysplastic syndromes].
    Ohyashiki K; Ohyashiki JH
    Nihon Rinsho; 1998 May; 56(5):1328-32. PubMed ID: 9613146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes.
    Ohyashiki JH; Iwama H; Yahata N; Ando K; Hayashi S; Shay JW; Ohyashiki K
    Clin Cancer Res; 1999 May; 5(5):1155-60. PubMed ID: 10353751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DCC protein expression in hematopoietic cell populations and its relation to leukemogenesis.
    Inokuchi K; Miyake K; Takahashi H; Dan K; Nomura T
    J Clin Invest; 1996 Feb; 97(3):852-7. PubMed ID: 8609244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
    Bernasconi P
    Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomeres and telomerase in leukaemia and lymphoma.
    Davison GM
    Transfus Apher Sci; 2007 Aug; 37(1):43-7. PubMed ID: 17766184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
    Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomeres, telomerase, and hematopoietic stem cell biology.
    Greenwood MJ; Lansdorp PM
    Arch Med Res; 2003; 34(6):489-95. PubMed ID: 14734088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.